Web Conference Archives

Part 3 and Part 4 Archives Available Now

Learning Objectives  - Part 3
  • Identify emerging therapies for Huntington's disease
  • Discuss the long-term efficacy and safety of pharmacotherapy in managing chorea
  • Summarize current Huntington's Study Group (HSG) clinical work
Learning Objectives  - Part 4
  • Identify emerging neuroprotective therapies for Huntington's disease
  • Discuss emerging treatment options for non-motor symptoms of Huntington's disease
  • Summarize current Huntington's Study Group (HSG) clinical work

PART 3 ARCHIVE
CLICK HERE to register for the Part 3 Archive, available for CME credit 
**WHEN PROMPTED, ENTER THE PASSWORD: treatment

PART 4 ARCHIVE
CLICK HERE to register for the Part 4 Archive, available for CME credit 
**WHEN PROMPTED, ENTER THE PASSWORD: casestudies

Note: These archives are direct recordings from the live presentations by the expert faculty on September 1, 2009 (Part 3), and November 12, 2009 (Part 4).  As such, minor pauses in the flow of content are natural due to the technology used for the event.


intellyst® Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
intellyst® Medical Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™ per web conference.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
  

intellyst® Medical Education acknowledges the unrestricted educational grant provided by Lundbeck Inc.